Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2018

01-06-2018 | Original Article

Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas

Authors: T. Mizumoto, T. Hiyama, S. Oka, N. Yorita, K. Kuroki, M. Kurihara, Y. Yoshifuku, Y. Sanomura, Y. Urabe, Y. Murakami, K. Arihiro, S. Tanaka, K. Chayama

Published in: Digestive Diseases and Sciences | Issue 6/2018

Login to get access

Abstract

Background

According to the Japanese Esophageal Society (JES) guidelines, risk factors for lymph node (LN) metastasis in the muscularis mucosa (MM)/submucosa to a depth of up to 200 μm (SM1) in cases of esophageal squamous cell carcinomas (ESCCs) include the presence of lymphatic invasion (ly), venous invasion (v), infiltration pattern (INF)c, and SM1. The long-term prognoses of these patients are unclear, and there are very few reports on the validation of the curative criteria for MM/SM1 ESCCs.

Aims

To examine the long-term prognoses of these patients and the risk factors for LN metastasis of MM/SM1 ESCCs after endoscopic resection (ER).

Methods

This study included patients with MM/SM1 ESCCs who underwent ER at Hiroshima University Hospital from December 1990 to November 2016. We evaluated the clinicopathological characteristics of 98 patients and overall survival, disease-specific survival, recurrence-free survival, and recurrence rates in the e-curative and non-e-curative groups.

Results

The mean observation period was 75 months. There was no significant difference in disease-specific survival rate between the e-curative and non-e-curative groups (100 vs. 98%). There was no significant difference in disease-specific survival rates between the groups (100 vs. 98%). In contrast, the LN recurrence-free survival rate in patients with INFa, ly(−), and v(−) was significantly higher than that in patients with INFb/c, ly(+), or v(+) (100 and 87%, P < 0.05).

Conclusion

Contrary to the JES guidelines, our findings suggest that new criteria (MM/SM1, INFa, negative vertical margin (VM0), ly[-], and v[-]) may be associated with curative ER without additional treatment.
Literature
1.
go back to reference Moreira LF, Kamikawa Y, Naomoto Y, Haisa M, Orita K. Endoscopic mucosal resection for superficial carcinoma and high-grade dysplasia of the esophagus. Surg Laparosc Endosc. 1995;5:171–175.PubMed Moreira LF, Kamikawa Y, Naomoto Y, Haisa M, Orita K. Endoscopic mucosal resection for superficial carcinoma and high-grade dysplasia of the esophagus. Surg Laparosc Endosc. 1995;5:171–175.PubMed
2.
go back to reference Urabe Y, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol. 2011;26:275–280.CrossRefPubMed Urabe Y, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol. 2011;26:275–280.CrossRefPubMed
3.
go back to reference Katada C, Muto M, Momma K, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae–a multicenter retrospective cohort study. Endoscopy. 2007;39:779–783.CrossRefPubMed Katada C, Muto M, Momma K, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae–a multicenter retrospective cohort study. Endoscopy. 2007;39:779–783.CrossRefPubMed
4.
go back to reference Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56:387–390.CrossRefPubMed Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56:387–390.CrossRefPubMed
5.
go back to reference Ono H. Endoscopic submucosal dissection for early gastric cancer. J Dig Dis. 2005;6:119–121. Ono H. Endoscopic submucosal dissection for early gastric cancer. J Dig Dis. 2005;6:119–121.
6.
go back to reference Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–694.CrossRefPubMed Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–694.CrossRefPubMed
7.
go back to reference Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005;3:S67–S70.CrossRefPubMed Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005;3:S67–S70.CrossRefPubMed
8.
go back to reference Takahashi H, Arimura Y, Masao H, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72:255–264.CrossRefPubMed Takahashi H, Arimura Y, Masao H, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72:255–264.CrossRefPubMed
9.
go back to reference Tsujii Y, Nishida T, Nishiyama O, et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study. Endoscopy. 2015;47:775–783.CrossRefPubMed Tsujii Y, Nishida T, Nishiyama O, et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study. Endoscopy. 2015;47:775–783.CrossRefPubMed
10.
go back to reference Nagami Y, Ominami M, Shiba M, et al. The five-year survival rate after endoscopic submucosal dissection for superficial esophageal squamous cell neoplasia. Dig Liver Dis. 2017;49:427–433.CrossRefPubMed Nagami Y, Ominami M, Shiba M, et al. The five-year survival rate after endoscopic submucosal dissection for superficial esophageal squamous cell neoplasia. Dig Liver Dis. 2017;49:427–433.CrossRefPubMed
11.
go back to reference Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–551.CrossRefPubMed Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–551.CrossRefPubMed
12.
go back to reference Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–866.CrossRefPubMed Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–866.CrossRefPubMed
13.
go back to reference Joo DC, Kim GH, Park DY, Jhi JH, Song GA. Long-term outcome after endoscopic sub-mucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver. 2014;8:612–618.CrossRefPubMedPubMedCentral Joo DC, Kim GH, Park DY, Jhi JH, Song GA. Long-term outcome after endoscopic sub-mucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver. 2014;8:612–618.CrossRefPubMedPubMedCentral
14.
go back to reference Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27:1000–1008.CrossRefPubMed Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27:1000–1008.CrossRefPubMed
15.
go back to reference Miwata T, Oka S, Tanaka S, et al. Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Surg Endosc. 2016;30:4049–4056.CrossRefPubMed Miwata T, Oka S, Tanaka S, et al. Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Surg Endosc. 2016;30:4049–4056.CrossRefPubMed
16.
17.
go back to reference Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–575.CrossRefPubMed Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–575.CrossRefPubMed
18.
go back to reference Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–480.CrossRefPubMed Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–480.CrossRefPubMed
19.
go back to reference Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–1293.CrossRefPubMed Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–1293.CrossRefPubMed
20.
go back to reference Oyama T. Lymph nodal metastasis of M3, SM1 esophageal cancer. Stom Intest. 2002;37:71–74. (in Japanese). Oyama T. Lymph nodal metastasis of M3, SM1 esophageal cancer. Stom Intest. 2002;37:71–74. (in Japanese).
21.
go back to reference Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefPubMed Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefPubMed
22.
go back to reference The Japanese Esophageal Society. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. Tokyo: Kanehara & Co Ltd.; 2012. (in Japanese). The Japanese Esophageal Society. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. Tokyo: Kanehara & Co Ltd.; 2012. (in Japanese).
23.
go back to reference Murakami Y, Nagata Y, Nishibuchi I, et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer. Int J Clin Oncol. 2012;17:263–271.CrossRefPubMed Murakami Y, Nagata Y, Nishibuchi I, et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer. Int J Clin Oncol. 2012;17:263–271.CrossRefPubMed
24.
go back to reference Murakami Y, Takahashi I, Nishibuchi I, et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0). Int J Clin Oncol. 2015;20:897–904.CrossRefPubMed Murakami Y, Takahashi I, Nishibuchi I, et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0). Int J Clin Oncol. 2015;20:897–904.CrossRefPubMed
25.
go back to reference Miura A, Momma K, Yoshida M. Endoscopic resection for T1a-MM and T1b-SM1 squamous cell carcinoma of the esophagus. Clin J Gastroenterol. 2009;2:252–256.CrossRefPubMed Miura A, Momma K, Yoshida M. Endoscopic resection for T1a-MM and T1b-SM1 squamous cell carcinoma of the esophagus. Clin J Gastroenterol. 2009;2:252–256.CrossRefPubMed
26.
go back to reference Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257:1032–1038.CrossRefPubMed Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257:1032–1038.CrossRefPubMed
27.
go back to reference Ito E, Ozawa S, Kijima H, et al. New invasive patterns as a prognostic factor for superficial esophageal cancer. J Gastroenterol. 2012;47:1279–1289.CrossRefPubMed Ito E, Ozawa S, Kijima H, et al. New invasive patterns as a prognostic factor for superficial esophageal cancer. J Gastroenterol. 2012;47:1279–1289.CrossRefPubMed
28.
go back to reference Arima M, Yamada T, Tsunomiya I, et al. Strategies for treatment and follow-up observation of patients with superficial esophageal cancer. Shoukakinaisikyou. 2012;24:1237–1244. (in Japanese). Arima M, Yamada T, Tsunomiya I, et al. Strategies for treatment and follow-up observation of patients with superficial esophageal cancer. Shoukakinaisikyou. 2012;24:1237–1244. (in Japanese).
29.
go back to reference Fukuhara T, Hiyama T, Tanaka S, et al. Natural course of lugol-voiding lesions in patients with superficial esophageal squamous cell carcinoma. Digestion. 2010;82:60–65.CrossRefPubMed Fukuhara T, Hiyama T, Tanaka S, et al. Natural course of lugol-voiding lesions in patients with superficial esophageal squamous cell carcinoma. Digestion. 2010;82:60–65.CrossRefPubMed
30.
go back to reference Fukuhara T, Hiyama T, Tanaka S, et al. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma. J Clin Gastroenterol. 2010;44:27–33.CrossRef Fukuhara T, Hiyama T, Tanaka S, et al. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma. J Clin Gastroenterol. 2010;44:27–33.CrossRef
31.
go back to reference Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39:638–643.CrossRefPubMed Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39:638–643.CrossRefPubMed
32.
go back to reference Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol. 2009;39:686–689.CrossRefPubMedPubMedCentral Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol. 2009;39:686–689.CrossRefPubMedPubMedCentral
Metadata
Title
Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas
Authors
T. Mizumoto
T. Hiyama
S. Oka
N. Yorita
K. Kuroki
M. Kurihara
Y. Yoshifuku
Y. Sanomura
Y. Urabe
Y. Murakami
K. Arihiro
S. Tanaka
K. Chayama
Publication date
01-06-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5029-0

Other articles of this Issue 6/2018

Digestive Diseases and Sciences 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine